Indian Journal of Cancer Home 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2022  |  Volume : 59  |  Issue : 2  |  Page : 212--217

Factors predicting contralateral nodal spread in papillary carcinoma of thyroid

Harish Verma1, Nija Shah2, Prateek Jain2, Kapila Manikantan2, Rajeev Sharan2, Pattatheyil Arun2 
1 Department of Surgical Oncology, Tata Medical Center, Kolkata, West Bengal, India
2 Department of Head and Neck Surgery, Tata Medical Center, Kolkata, West Bengal, India

Correspondence Address:
Pattatheyil Arun
Department of Head and Neck Surgery, Tata Medical Center, Kolkata, West Bengal
India

Background: Lymph node metastasis (LNM) is evident in about 20–50% of cases at presentation in papillary carcinoma thyroid (PTC). There are no clear recommendations for the need and extent of lateral and central compartment dissection in PTC. Methods: A total of 83 patients who underwent total thyroidectomy and bilateral selective neck dissection for diagnosed PTC from September 2011 to October 2017 were retrospectively analyzed. Results: Tumor site was bilobar or involving isthmus in 40 patients. Contralateral LNM was seen in 42 patients. Both radiological (median size 2.6 cm, P = 0.051) and pathological (median size 3.65 cm, P = 0.015) size of tumor, tumor involving isthmus or bilateral lobes (P = 0.006), and lymphovascular invasion (LVI) (P = 0.026) had significant correlation with contralateral LNM. Conclusion: Size and site of tumor, ipsilateral lateral compartment nodes involvement, and LVI status of tumor significantly increases the probability of contralateral LNM in patients of PTC.


How to cite this article:
Verma H, Shah N, Jain P, Manikantan K, Sharan R, Arun P. Factors predicting contralateral nodal spread in papillary carcinoma of thyroid.Indian J Cancer 2022;59:212-217


How to cite this URL:
Verma H, Shah N, Jain P, Manikantan K, Sharan R, Arun P. Factors predicting contralateral nodal spread in papillary carcinoma of thyroid. Indian J Cancer [serial online] 2022 [cited 2022 Nov 26 ];59:212-217
Available from: https://www.indianjcancer.com/article.asp?issn=0019-509X;year=2022;volume=59;issue=2;spage=212;epage=217;aulast=Verma;type=0